TGFB1 and lip and oral cavity carcinoma: Future work on the TGF-β signaling mechanisms that operate in oral cancer may reveal new therapeutic targets, such as small-molecule TGF-β inhibitors, that broaden the range of drug development and even prevent or cure oral cancer.